Clinical effect of the drug "Prostamol-Uno" in patients with benign prostatic hyperplasia and chronic prostatitis
Mazo, E.B.; Dmitriev, D.G.
Urologiia 5: 38-41
2001
ISSN/ISBN: 1728-2985 PMID: 11641979 Document Number: 6343
Document emailed within 1 workday
Related Documents
Wu, X.-j.; Yang, L.-y.; Zhang, X.-z. 2008: A clinical analysis of benign prostatic hyperplasia with chronic prostatitis Zhonghua Nan Ke Xue 14(6): 527-529Zhiborev, A.B.; Martov, A.G. 2018: The effectiveness of the integrated approach to the treatment of chronic prostatitis, including in patients with benign prostatic hyperplasia Urologiia 4: 81-87
Gao, W.-J.; Wang, Y.-M.; Wang, C.-H.; Yang, X.-K.; Wan, L.; Li, W.-P. 2013: Expressions of SIgA and alpha 1-AR in benign prostatic hyperplasia combined with chronic prostatitis and their implications Zhonghua Nan Ke Xue 19(4): 315-320
Yang, G.-Q.; Li, S.-W.; Zheng, H.; Zhang, W.-B.; Hu, W.-L.; Zheng, X.-M. 2009: Expression of estrogen receptor beta in benign prostatic hyperplasia complicated by chronic prostatitis Zhonghua Nan Ke Xue 15(4): 314-317
Aliaev, I.G.; Vinarov, A.Z.; Lokshin, K.L.; Spivak, L.G. 2006: Efficiency and safety of prostamol-Uno in patients with chronic abacterial prostatitis Urologiia 31(1): 47-50
Nishimoto, K. 1990: Clinical evaluation of isometric detrusor pressure in patients with benign prostatic hyperplasia Hinyokika Kiyo. Acta Urologica Japonica 36(1): 19-26
Ikeuchi, T.; Ueno, M. 1993: Clinical studies on chronic prostatitis and prostatitis-like syndrome (6). Clinical evaluation for the chronic prostatitis-like syndrome patients with severe symptoms of voiding and abnormal uroflowmetric results Hinyokika Kiyo. Acta Urologica Japonica 39(4): 321-325
Ekman, P. 1992: Drug therapy of benign prostatic hyperplasia Lakartidningen 89(45): 3803-3804
Brannen, G.E.; Coffey, D.S. 1977: Tumor-specific immunity in patients with prostatic adenocarcinoma or benign prostatic hyperplasia Cancer Treatment Reports 61(2): 211-216
Abdul-Muhsin, H.M.; Jakob, N.J.; McLemore, R.M.; McAdams, S.B.; Humphreys, M.R. 2016: Infectious complications associated with the use of temporary prostatic urethral stents in patients with benign prostatic hyperplasia Canadian Journal of Urology 23(5): 8465-8470
Spivak, L.G.; Lokshin, K.L.; Vinarov, A.Z. 2015: Review of Clinical Studies on Combination Therapy of 5α-Reductase Inhibitors and Α1-Blockers in Patients with Benign Prostatic Hyperplasia Urologiia 2015(4): 125-133
Jonas, U.; Melchior, H.; Rübben, H. 1998: Recommendations for billing alternative therapy of benign prostatic hyperplasia. Laser therapy of benign prostatic hyperplasia Der Urologe. Ausg. a 37(1): 110-111
Kupriyanov, Y.A.; Rasner, P.I.; Rokhlikov, I.M.; Akrikidi, A.A.; Soloviev, V.V.; Markov, A.A.; Nozdrin, E.V.; Logvinov, L.A.; Vasilevskiy, R.P.; Skrupskiy, K.S.; Pushkar, D.Y.; Putilovskiy, M.A.; Epstein, O.I. 2019: The experience of using drug Afalaza for treatment of lower urinary symptoms in treatment-nave patients with benign prostatic hyperplasia Urologiia 3: 36-42
Drsata, J. 2002: Enzyme inhibition in the drug therapy of benign prostatic hyperplasia Casopis Lekaru Ceskych 141(20): 630-635
Deng, Z.-X.; Ji, L.-X.; Zhang, Y.-R.; Li, C.-d.; Cai, J.; Jiang, H.-H. 2018: Ningmitai Capsules relieve lower urinary tract symptoms in patients with benign prostatic hyperplasia : a short-term clinical observation Zhonghua Nan Ke Xue 24(1): 72-77
Madsen, F.A.; Bruskewitz, R.C. 1995: Clinical manifestations of benign prostatic hyperplasia Urologic Clinics of North America 22(2): 291-298
Bogdanowicz, J.F.; Bentvelsen, F.M.; Oosterom, R.; Schroeder, F.H. 1991: Evaluation of prostate-specific antigen and prostatic acid phosphatase in untreated prostatic carcinoma and benign prostatic hyperplasia Scandinavian Journal of Urology and Nephrology. Supplementum 138: 97-103
Vinarov, A.Z.; Aliaev, I.G.; Apolikhin, O.I.; Mazo, E.B.; Darenkov, S.P.; Demidko, I.L.; Lokshin, K.L.; Medvedev, A.A.; Permiakova, O.V.; Spivak, L.G.; Shkol'nikov, M.E. 2010: Results of three-year clinical study of prostamol uno efficacy and safety in patients with initial symptoms of prostatic adenoma and risk of its progression Urologiia 6: 3-10
Djavan, B.; McConnell, J. 1996: The effect of 5-alpha-reductase inhibitors on benign prostatic hyperplasia Wiener Medizinische Wochenschrift 146(8): 165-168
Song, Y.; Li, N.-c.; Wang, X.-f.; Ma, L.-l.; Wan, B.; Hong, B.-f.; Na, Y.-q. 2005: Clinical study of Eviprostat for the treatment of benign prostatic hyperplasia Zhonghua Nan Ke Xue 11(9): 674-676